Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2915
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07024862 | Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy | ||
| NCT04933903 | BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab | ||
| NCT00300027 | Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies | ||
| NCT00000953 | Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients | ||
| NCT01460160 | Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia | ||
| NCT05605782 | A Post-Authorization, Long-term Study of Ozanimod Real-world Safety | ||
| NCT00866905 | Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer | ||
| NCT05337137 | A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer | ||
| NCT03624127 | Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis | ||
| NCT00099606 | Phase I (PH I) Mad Refractory Solid Tumor Study | ||
| NCT07255404 | A Clinical Trial Testing the Safety of BNT327 (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer | ||
| NCT05780736 | A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer | ||
| NCT04895709 | A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors | ||
| NCT00558506 | Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis | ||
| NCT04080804 | Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer | ||
| NCT05704933 | Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases | ||
| NCT04150471 | Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients | ||
| NCT01396252 | Japanese Phase 1 Multiple Ascending Dose (MAD) Study | ||
| NCT06181630 | A Lactation Study in Women Receiving Treatment With Ozanimod | ||
| NCT04515628 | Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants | ||
| NCT07629999 | Single and Multiple Dose Study to Evaluate Safety and Pharmacokinetics of BMS-986533 in Healthy Participants and Assessments of Food and pH Effects on Relative Bioavailability, and Drug-Drug Interaction Potential in Healthy Participants | ||
| NCT00901498 | Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease | ||
| NCT00101816 | Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate | ||
| NCT04161781 | A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer | ||
| NCT07544628 | A Phase 1 Study of Navlimetostat Tablet Formulations | ||
| NCT01940198 | Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia | ||
| NCT01218477 | Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML) | ||
| NCT01836705 | Effect of SAR302503 on ECG Activity in Patients With Solid Tumors | ||
| NCT00371683 | Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery | ||
| NCT00820170 | Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 | ||
| NCT03205722 | The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany | ||
| NCT01696045 | Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma | ||
| NCT03250273 | A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma | ||
| NCT02045966 | Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects | ||
| NCT05218902 | A Study of Azacitidine in Participants With International Prognostic Scoring System (IPSS) Intermediate-2 and High-risk Myelodysplastic Syndromes (MDS), or Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML) | ||
| NCT00028301 | Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s) | ||
| NCT04016753 | A Study Measuring the Effectiveness of BMS-986256 Combined With Oral Contraceptive in Healthy Female Participants | ||
| NCT00313300 | Safety Study of Apixaban in Recent Acute Coronary Syndrome | ||
| NCT00696072 | Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic | ||
| NCT02499367 | Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients | ||
| NCT05150236 | EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC | ||
| NCT00825734 | Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer | ||
| NCT01094795 | Safety Study of Abatacept in Sweden | ||
| NCT02498912 | Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors | ||
| NCT04115059 | Dasatinib In Waldenström Macroglobulinemia | ||
| NCT02447341 | Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study) | ||
| NCT00162305 | A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects | ||
| NCT07061288 | A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT | ||
| NCT00252005 | Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study | ||
| NCT05077956 | Sema 4A as a Marker for Inflammatory Disease in Multiple Sclerosis |
